Clinical Trial Update: A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers [Phase 1]

View source ↗

Summary

A Phase I clinical trial update for HDFL48 in patients with recurrent or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HDFL48

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Recurrent or Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED